title: Aspirin use and potential mechanisms for colorectal cancer prevention.
authors.affiliation: Department of Cell Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2279, USA.
authors.forename: C S
authors.initials: CS
authors.lastname: Williams
authors.forename: W
authors.initials: W
authors.lastname: Smalley
authors.forename: R N
authors.initials: RN
authors.lastname: DuBois
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry; D018256:Adenomatous Polyps / Q000737:chemistry / Q000503:physiopathology / Q000517:prevention & control*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000737:chemistry / Q000503:physiopathology / Q000517:prevention & control*; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007527:Isoenzymes / Q000032:analysis / Q000502:physiology*; D008297:Male; D008565:Membrane Proteins; D051379:Mice; D011451:Prostaglandin-Endoperoxide Synthases / Q000032:analysis / Q000502:physiology*; D016032:Randomized Controlled Trials as Topic; D013467:Sulindac / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D013467:Sulindac; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin